MIAMI, FL / ACCESS Newswire / November 12, 2025 / iTolerance, Inc. (“iTolerance” or the “Company”), an early-stage ...
ORKA-001 Phase 1 results presented at EADV show potential for once-per-year dosing, higher efficacy and off-treatment remission Over $500M cash and equivalents provides runway over one year past three ...
Crop biotechnology is like giving plants superpowers! It’s using science to make plants better, like helping them fight off ...
Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
Detailed price information for Crescent Biopharma Inc (CBIO-Q) from The Globe and Mail including charting and trades.
Now, there’s a new player in town called CancerVax, and it’s getting a lot of attention. This article is going to look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback